Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...